The largest database of trusted experimental protocols

Remazol brilliant blue xylan

Manufactured by Merck Group
Sourced in United States

Remazol Brilliant Blue Xylan is a lab equipment product used for the analysis and quantification of xylan, a type of hemicellulose found in plant cell walls. It provides a colorimetric method for the detection and measurement of xylan content in various samples.

Automatically generated - may contain errors

2 protocols using remazol brilliant blue xylan

1

Screening and Characterization of Chimeric Xylanase Enzyme

Check if the same lab product or an alternative is used in the 5 most similar protocols
The XBP+/XynA+ clones were grown in TB supplemented with 34 µg/mL kanamycin, 100 µg/mL ampicillin for 48 h in 96-well plates (deep well). The supernatants were analyzed for hydrolysis of Remazol Brilliant Blue Xylan (RBB-xylan, Sigma-Aldrich, St. Louis, Missouri, USA), using a modification of a previously described protocol [35 (link)]. Fifty µL of culture supernatant was mixed with 50 µL of a solution containing RBB-xylan (4 mg/mL) in 100 mM acetate buffer (pH 5.5), in the presence or absence of 1 % (m/v) d-xylose (Sigma-Aldrich, St. Louis, Missouri, USA), and incubated at 37 °C for 12 h. After incubation, the reaction was stopped by the addition of 2 volumes (200 µL) of 96 % (v/v) ethanol. The insoluble material was removed by centrifugation (2000g/2 minutes), and the increase in the absorbance of the supernatant was measured at 595 nm. A single clone that showed activity ratio (with xylose)/(without xylose) greater than 1.3 was selected, and nucleotide sequencing indicated that the XynA domain was inserted within the XBP at position 271, and this chimeric enzyme was denominated as XynA–XBP271.
+ Open protocol
+ Expand
2

Screening XynA+ Xylanase Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
The XynA+ clones were grown in TB supplemented with 34 µg/mL kanamycin, 50 µg/mL streptomycin and 0.5 mM IPTG for 48 h in 96-well plates (deep well). The supernatants were analyzed for hydrolysis of RBB-xylan (Remazol Brilliant Blue Xylan, Sigma), using a modification of the protocol developed by Biely et al. [63 (link)]. In this protocol, 50 µL of supernatants was mixed with 50 µL of a solution containing RBB-xylan (4 mg/mL), in 100 mM acetate buffer (pH 5.5), in the presence or absence of 1% (m/v) d-xylose (Sigma), and incubated at 37°C for 12 h. After incubation, the reaction was stopped by the addition of two volumes (200 µL) of 96% (v/v) ethanol. The insoluble material was removed by centrifugation (2,000g/2 min), and the increase in the absorbance of the supernatant was monitored at 595 nm. The clones that showed the highest activity in the presence of d-xylose compared to the absence of d-xylose were selected.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!